Neuronetics (STIM) Shares Outstanding (Weighted Average) (2016 - 2026)

Neuronetics (STIM) has 11 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 96.83% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 96.83% YoY) and the FY2025 annual result came in at $2.0 million, up 13.04% from the prior year.
• Shares Outstanding (Weighted Average) held at $2.0 million in Q1 2026 per STIM's latest filing, from $2.0 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $65.0 million in Q3 2025 and bottomed at $61000.0 in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $26.9 million (2022), against an average of $24.9 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) sank 99.77%; it then surged 48690.16% in 2024.
• Tracing STIM's Shares Outstanding (Weighted Average) over 5 years: stood at $26.9 million in 2022, then grew by 6.54% to $28.7 million in 2023, then slumped by 93.98% to $1.7 million in 2024, then gained by 13.04% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
• Per Business Quant, the three latest STIM Shares Outstanding (Weighted Average) figures stand at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $65.0 million (Q3 2025).

Peer Comparison